A Phase 1b Study to Evaluate the Safety and Efficacy of Durvalumab in Combination with Tremelimumab or Danvatirsen in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Publication date: Available online 17 December 2020Source: Clinical Lymphoma Myeloma and LeukemiaAuthor(s): Vincent Ribrag, Seung Tae Lee, David Rizzieri, Martin JS. Dyer, Luis Fayad, Razelle Kurzrock, Leslie Andritsos, Reda Bouabdallah, Amjad Hayat, Larry Bacon, Yu Jiang, Kowser Miah, Bruno Delafont, Oday Hamid, Stephanie Anyanwu, Pablo Martinez, Brian Hess
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research